FIELD: medicine; pharmacology.
SUBSTANCE: composition includes effective amount of carbamazepine as active ingredient, and carbomer 71G, microcrystalline cellulose, sodium carboxymethylstarch, aerosol, and stearate salt as auxiliary ingredients. The composition is manufactured by direct pressing method, preferably in form of tablets.
EFFECT: composition stability during storage period, release profile reproducibility of active substance, satisfactory pharmacokinetic characteristics, and high strength of the tablets.
5 cl, 1 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION ELICITING ANTICONVULSANT AND PSYCHOTROPIC EFFECT AND METHOD FOR ITS PREPARING | 2003 |
|
RU2240798C1 |
ANTICONVULSANT AND PSYCHOTROPIC AGENT AND METHOD OF ITS PREPARING | 1999 |
|
RU2157212C1 |
PENTOXYPHYLLINE-BASE DRUG | 2001 |
|
RU2190408C1 |
PHARMACEUTICAL AGENT WITH CARDIOVASCULAR EFFECT | 2001 |
|
RU2206316C1 |
PHARMACEUTICAL COMPOSITION OF ANTIEPILEPTIC ACTIVITY AND METHOD OF PRODUCTION THEREOF | 2007 |
|
RU2345777C1 |
PHARMACEUTICAL COMPOSITION OF ANTIHYPERTENSIVE AND DIURETIC ACTION, AND METHOD FOR ITS OBTAINING | 2002 |
|
RU2201751C1 |
ANTIAGGREGATE AGENT IMPROVING CEREBRAL CIRCULATION AND METHOD OF ITS PREPARING | 2000 |
|
RU2157209C1 |
CARBAMAZEPIN-BASE DRUG | 2001 |
|
RU2189225C1 |
DRUG BASED ON TETRAMETILTETRAAZOBITSIKLOOKTANDION AND METHOD FOR ITS PRODUCTION | 2012 |
|
RU2611194C2 |
METHOD OF OBTAINING MEDICAL FORM OF TRIMETAZIDINE OF PROLONGED ACTION | 2012 |
|
RU2530558C2 |
Authors
Dates
2008-12-27—Published
2007-04-05—Filed